While early studies suggested that increased IFNγ levels correlate with improved clinical outcomes in patients with ovarian cancer [62], more recent studies have shown that high IFNγ expression in OC tissues promotes cancer progression and correlates with poor survival [36,46,63]. This evidence concerns the gene IFNG and ovarian cancer.